In the past three years, Dr. Lam was a non-executive director of National Arts Group Holdings Limited up to July 2022, Tianda Pharmaceuticals Limited up to August 2021 and China Shandong Hi-Speed Financial Group Limited up to May 2020, and he was also an independent non-executive director of Aurum Pacific (China) Group Limited up to March 2021 and Huarong Investment Stock Corporation Limited up to December 2020. He was an independent non-executive director of each of Top Global Limited up to August 2021 and Sunwah International Limited up to June 2021. With effect from 21 April 2023, the composition of the Nomination Committee, Audit Committee and Remuneration Committee has been changed respectively as follows: The Nomination Committee: Mr. Yu Chun Kit (chairman), Mr. Yip Wai Ming, Dr. LAM, Lee G., BBS, JP; The Audit Committee: Mr. Yip Wai Ming (chairman), Mr. Yu Chun Kit, Dr. LAM, Lee G., BBS, JP; The Remuneration Committee: Dr. LAM, Lee G., BBS, JP (chairman), Mr. Yip Wai Ming, Mr. Yu Chun Kit.